Fabrice Egros

Fabrice Egros is currently Chairman at Multicare Pharmaceuticals Philippines, Inc. and neo CritiCare Pharma Co., Ltd. He serves as Director at Biotechnology Innovation Organization, Generic Health Pty Ltd., and YL Biologics Ltd. Since 2015, Dr. Egros has been with Lupin Ltd., currently holding the position of President-Corporate Development since 2022.
Formerly, Dr. Egros was Deputy Chief Executive Officer, COO & Director at NovaMedica LLC from 2012 to 2015.
Dr. Egros was Chairman at Kyowa Pharmaceutical Industry Co., Ltd. Dr. Egros was Independent Director at Syndax Pharmaceuticals, Inc. from 2013 to 2022.
Dr. Egros was SVP-Corporate Business Development & Strategy at UCB SA in 2011.
Dr. Egros was Chief Operating Officer at Xanodyne Pharmaceuticals, Inc. from 2011 to 2012.
Dr. Egros held the SVP-Corporate Business Development & Strategy role at UCB Pharma, Inc. Dr. Egros was Vice President at Sanofi-Aventis U.S.
LLC.
Dr. Egros was President at UCB, Inc. in 2009.
Dr. Egros was President at UCB Japan Co. Ltd. in 2006.
Education includes undergraduate studies at Harvard University and the University of Chatenay-Malabry, graduate studies at the University of Orsay, and a doctorate from the University of Chatenay-Malabry.